A2M - alpha-2-macroglobulin Gene
Also Known as A2MD; CPAMD5; FWP007; S863-7
Species: Homo sapiens
About A2M
This gene has 13 transcripts (splice variants), 228 orthologues and 8 paralogues. Broad expression in lung (RPKM 732.0), urinary bladder (RPKM 374.7) and 21 other tissues.
Summary
The protein encoded by this gene is a protease inhibitor and cytokine transporter. It uses a bait-and-trap mechanism to inhibit a broad spectrum of proteases, including trypsin, Thrombin and collagenase. It can also inhibit inflammatory cytokines, and it thus disrupts inflammatory cascades. Mutations in this gene are a cause of alpha-2-macroglobulin deficiency. This gene is implicated in Alzheimer's disease (AD) due to its ability to mediate the clearance and degradation of A-beta, the major component of beta-amyloid deposits. A related pseudogene, which is also located on the p arm of chromosome 12, has been identified. [provided by RefSeq, Nov 2016]
A2M Products (4)
| mRNA | Protein | Name |
|---|---|---|
| NM_000014.6 | NP_000005.3 | alpha-2-macroglobulin isoform a precursor |
| NM_001347423.2 | NP_001334352.2 | alpha-2-macroglobulin isoform a precursor |
| NM_001347424.2 | NP_001334353.2 | alpha-2-macroglobulin isoform b |
| NM_001347425.2 | NP_001334354.2 | alpha-2-macroglobulin isoform c |
| Molecular Function GO Annotation | Evidence | References | Source |
|---|---|---|---|
| enables calcium-dependent protein binding |
IPI
IPI: Inferred from physical interaction
|
15226301 | GOA |
| enables endopeptidase inhibitor activity |
IDA
IDA: Inferred from direct assay
|
7679575 | GOA |
| enables enzyme binding |
IPI
IPI: Inferred from physical interaction
|
11435418 | GOA |
| enables growth factor binding |
IDA
IDA: Inferred from direct assay
|
9398211 | GOA |
| enables interleukin-1 binding |
IDA
IDA: Inferred from direct assay
|
9714181 | GOA |
| enables interleukin-8 binding |
IPI
IPI: Inferred from physical interaction
|
10880251 | GOA |
| enables protease binding |
IPI
IPI: Inferred from physical interaction
|
7679575 | GOA |
| enables protein binding |
IPI
IPI: Inferred from physical interaction
|
6698368 | GOA |
| enables serine-type endopeptidase inhibitor activity |
IDA
IDA: Inferred from direct assay
|
12538697 | GOA |
| enables signaling receptor binding |
IMP
IMP: Inferred from mutant phenotype
|
15226301 | GOA |
| enables tumor necrosis factor binding |
IDA
IDA: Inferred from direct assay
|
9714181 | GOA |
| Biological Process GO Annotation | Evidence | References | Source |
|---|---|---|---|
| involved in negative regulation of complement activation, lectin pathway |
IDA
IDA: Inferred from direct assay
|
12538697 | GOA |
A2M Protein Structure
A2M_N: MG2 domain (129 - 221)
A2M_N_2: Alpha-2-macroglobulin family N-terminal region (459 - 607)
A2M: Alpha-2-macroglobulin family (738 - 828)
Thiol-ester_cl: Alpha-macro-globulin thiol-ester bond-forming region (961 - 991)
A2M_comp: A-macroglobulin complement component (1010 - 1265)
A2M_recep: A-macroglobulin receptor (1376 - 1463)
- 0
- 300
- 600
- 900
- 1200
- 1474 a.a.
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
alpha-2-macroglobulin |
|
A2M Protein-protein interaction Information
|
Type
|
Protein Name | Protein ID | Interactor | Interactor Species | Interactor ID | Detection Method | References |
|---|---|---|---|---|---|---|---|
|
Intra
|
A2M | P01023 | KAT5 | Homo sapiens | Q92993-2 | 32814053 | |
|
Intra
|
A2M | P01023 | KAT5 | Homo sapiens | Q92993-2 | 32814053 | |
|
Intra
|
A2M | P01023 | KAT5 | Homo sapiens | Q92993-2 | 32814053 | |
|
Intra
|
A2M | P01023 | VPS33A | Homo sapiens | Q96AX1 | 32814053 | |
|
Intra
|
A2M | P01023 | VPS33A | Homo sapiens | Q96AX1 | 32814053 | |
|
Intra
|
A2M | P01023 | VPS33A | Homo sapiens | Q96AX1 | 32814053 | |
|
Intra
|
A2M | P01023 | SMN1 | Homo sapiens | Q16637-3 | 32814053 | |
|
Intra
|
A2M | P01023 | SMN1 | Homo sapiens | Q16637-3 | 32814053 | |
|
Intra
|
A2M | P01023 | SMN1 | Homo sapiens | Q16637-3 | 32814053 | |
|
Intra
|
A2M | P01023 | CTNNB1 | Homo sapiens | P35222 | 32814053 | |
|
Intra
|
A2M | P01023 | CTNNB1 | Homo sapiens | P35222 | 32814053 | |
|
Intra
|
A2M | P01023 | CTNNB1 | Homo sapiens | P35222 | 32814053 | |
|
Intra
|
A2M | P01023 | TXN | Homo sapiens | P10599 | 32814053 | |
|
Intra
|
A2M | P01023 | TXN | Homo sapiens | P10599 | 32814053 | |
|
Intra
|
A2M | P01023 | TXN | Homo sapiens | P10599 | 32814053 | |
|
Intra
|
A2M | P01023 | PIAS1 | Homo sapiens | O75925 | 32814053 | |
|
Intra
|
A2M | P01023 | PIAS1 | Homo sapiens | O75925 | 32814053 | |
|
Intra
|
A2M | P01023 | PIAS1 | Homo sapiens | O75925 | 32814053 | |
|
Cross
|
A2M | P01023 | Ppif | Mus musculus | Q99KR7 | 32814053 | |
|
Cross
|
A2M | P01023 | Ppif | Mus musculus | Q99KR7 | 32814053 | |
|
Cross
|
A2M | P01023 | Ppif | Mus musculus | Q99KR7 | 32814053 |
Recombinant A2M Proteins
| Cat. No. | Product Name | Accession | Purity |
|---|---|---|---|
| HY-P72823 | Alpha-2-macroglobulin Protein, Human (sf9, His) | NP_000005.2 (S24-A1474) | ≥ 85%, as determined by reducing SDS-PAGE. |
A2M Antibodies
| Cat. No. | Product Name | Application | Reactivity |
|---|---|---|---|
| HY-P83560 | Alpha-2-Macroglobulin Antibody (YA3305) | WB, IHC-P | Human |
Related Diseases
| Diseases | Alias | |
|---|---|---|
| Alpha-2-Macroglobulin Deficiency |
|
|
| Mastitis |
|
|
| Subendocardial Myocardial Infarction |
|
|
| Nephrotic Syndrome |
|
|
| Cerebral Amyloid Angiopathy, Cst3-Related |
|
|
| Breast Intraductal Papillomatosis |
|
|
| Disseminated Chorioretinitis |
|
|
| Alzheimer Disease, Familial, 1 |
|
|
| Cystic Fibrosis |
|
|
| Deficiency Anemia |
|
|
Orthologs Information
| Species | Symbol | Source | ID |
|---|---|---|---|
| Rattus norvegicus | A2M | RGD | RGD:2004 |
| Felis catus | A2M | VGNC | VGNC:97332 |
| Mus musculus | A2M | MGD | MGI:2449119 |
| Bos taurus | A2M | VGNC | VGNC:55837 |
| Others | A2M | NCBI |